Engineered immune cells take on relapsed leukemia in new trial
NCT ID NCT06447987
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tests a treatment called CAR T cell therapy for adults with a type of blood cancer (B-cell acute lymphoblastic leukemia) that has returned or not responded to standard treatments. The therapy involves taking a patient's own immune cells, modifying them in a lab to better recognize and attack cancer cells, and giving them back via an infusion. The goal is to see if this approach is safe and effective for these hard-to-treat cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.